Malalties infeccioses-inflamatòries en animals de companyia (MIAC)

Organisation profile

Organisation profile

Aquest grup de recerca consolidat ha estat treballant conjuntament en els últims anys (2012-2022). El MIAC centra la seva recerca clínica i aplicada en l’estudi de malalties infeccioses e inflamatòries que afecten el gos, el gat i el cavall, sobretot en l’àmbit de l’epidemiologia, genètica, la patogènesi, la immunologia, el  diagnòstic, el tractament, el pronòstic i la prevenció. Les malalties infeccioses zoonòtiques més estudiades pel grup són la leishmaniosi canina, felina i equina, i la bartonellosi canina, felina i humana així com la febre del nil. El grup també treballa amb malalties inflamatòries com pèmfig foliaci o dermatitis atòpica així com amb medicina transfusional i regenerativa. L’objectiu general del MIAC és incrementar la recerca d’excel•lència i avançar en el coneixement de malalties infeccioses e inflamatòries en animals de companyia l'home d’una forma multidisciplinar i sota el paraigües de conceptes com una salut única i la biomedicina comparativa.

Directed by:

Laia Solano-Gallego

Research lines

  • Research lines:
  • Research line on epidemiology, genetics (application of whole genome sequencing and clinical metagenomics techniques), pathogenesis, clinical immunology, clinical aspects, diagnostic and prognostic markers (resistance or susceptibility) and resistance to drugs for canine, feline and equine leishmaniasis from a One Health perspective.
  • Research line in clinical studies on new drugs for the treatment (nanomedicine) of leishmaniasis in sick dogs such as the development of new immunomodulators or vaccines for the prevention of canine leishmaniasis as well as their use in healthy or sick infected dogs (immunotherapy).
  • Research line on epidemiology and clinical and immunological aspects of West Nile fever which is a viral disease that affects horses, other animals and humans. Research line on epidemiology, early detection and therapeutic improvements of infection by equine herpesvirus type I (EHV-1) and the neurological picture of myeloencephalopathy by EHV-1. Research line on metabolomics techniques to validate new biomarkers of inflammatory and infectious diseases in horses and other companion animals.
  • Research line on the pathogenesis (microbiome and clinical metagenomics) and diagnostic and prognostic markers (resistance or susceptibility) and resistance to drugs in other inflammatory skin diseases such as pyoderma, atopic dermatitis or sterile neutrophilic dermatitis among others.
  • Research line on the delivery of advanced therapeutic regimens such as blood transfusion medicine, stem cell therapy and organ transplantation and minimally invasive and reconstructive surgery in dogs, cats and horses (examples of perianal fistula, intra-articular treatments, canine and feline cornea and scleral graft).

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Dive into the research topics where Malalties infeccioses-inflamatòries en animals de companyia (MIAC) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further
View all 8 profiles
View all 152 research outputs